Fecal immunochemical test in cancer screening – colonoscopy outcome in FIT positives and negatives

References

• Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013;(9):CD009259. DOI:10.1002/14651858.CD009259.pub2.
   PubMed Web of Science ®Google Scholar
• Altobelli E, D'Aloisio F, Angeletti PM. Colorectal cancer screening in countries of European Council outside of the EU-28. World J Gastroenterol. 2016;22:4946–4957.
   PubMed Web of Science ®Google Scholar
• Benson VS, Atkin WS, Green J, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network. Int J Cancer. 2012;130:2961–2973.
   PubMed Web of Science ®Google Scholar
• Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105:2017–2025.
   PubMed Web of Science ®Google Scholar
• Ciatto S, Martinelli F, Castiglione G, et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the florence screening programme. Br J Cancer. 2007;96:218–221.
   PubMed Web of Science ®Google Scholar
• Digby J, Fraser CG, Carey FA, et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. J Clin Pathol. 2013;66:415–419.
   PubMed Web of Science ®Google Scholar
• de Wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107:1570–1578.
   PubMed Web of Science ®Google Scholar
• van Roon AH, Wilschut JA, Hol L, et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011;9:333–339.
   PubMed Web of Science ®Google Scholar
• Wong MC, Ching JY, Chan VC, et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens. Clin Gastroenterol Hepatol. 2015;13:1472–1479.
   PubMed Web of Science ®Google Scholar
• Rozen P, Levi Z, Hazazi R, et al. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Aliment Pharmacol Ther. 2009;29:906–917.
   PubMed Web of Science ®Google Scholar
• Kapidzic A, van Roon AH, van Leerdam ME, et al. Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer. Gut. 2017;66(1):118-123.
   Web of Science ®Google Scholar
• Guittet L, Bouvier V, Mariotte N, et al. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer. 2009;125:1127–1133.
   PubMed Web of Science ®Google Scholar
• Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer. 2009;100:259–265.
   PubMed Web of Science ®Google Scholar
• Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–815.
   PubMed Web of Science ®Google Scholar
• Haug U, Kuntz KM, Knudsen AB, et al. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer. 2011;104:1779–1785.
   PubMed Web of Science ®Google Scholar
• Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–428.
   PubMed Web of Science ®Google Scholar
• Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol. 2010;105:2457–2464.
   PubMed Web of Science ®Google Scholar
• Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Risk factors for false positive and for false negative test results in screening with fecal occult blood testing. Int J Cancer. 2013;133:2408–2414.
   PubMed Web of Science ®Google Scholar
• Wilen HR, Blom J, Hoijer J, et al. Fecal Immunochemical test (FIT) in colorectal cancer screening colonoscopy findings by different cut-off levels. J Gastroenterol Hepatol. 2019;34(1):103-112.
   Google Scholar
• Rolf Hultcrantz. Available from: https://clinicaltrials.gov/ct2/show/NCT02078804.
   Google Scholar
• Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Kaminski MF, Loberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176:894–902.
   PubMed Web of Science ®Google Scholar
• Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 2014;63:466–471.
   PubMed Web of Science ®Google Scholar
• Morikawa T, Kato J, Yamaji Y, et al. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol. 2007;102:2259–2264.
   PubMed Web of Science ®Google Scholar
• Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of immunochemical fecal occult blood tests. JAMA. 2010;304:2513–2520.
   PubMed Web of Science ®Google Scholar
• Levi Z, Rozen P, Hazazi R, et al. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. Am J Gastroenterol. 2009;104:933–938.
   PubMed Web of Science ®Google Scholar
• Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 2012;13:55–64.
   PubMed Web of Science ®Google Scholar
• Thorlacius H, Björk J, Öst Å, et al. Available from: http://www.lakartidningen.se/Klinik-och-vetenskap/Klinisk-oversikt/2017/05/Riktlinjer-for-endoskopisk-kontroll-efter-kolorektal-polypektomi/
   Google Scholar
• Chang LC, Shun CT, Hsu WF, et al. Fecal immunochemical test detects sessile serrated adenomas and polyps with a low level of sensitivity. Clin Gastroenterol Hepatol. 2017;15(6):872-879.e1.
   Web of Science ®Google Scholar
• Kapidzic A, van der Meulen MP, Hol L, et al. Gender differences in fecal immunochemical test performance for early detection of colorectal neoplasia. Clin Gastroenterol Hepatol. 2015;13:1464–1471e4.
   PubMed Web of Science ®Google Scholar
• van der Vlugt M, Grobbee EJ, Bossuyt PMM, et al. Interval colorectal cancer incidence among subjects undergoing multiple rounds of fecal immunochemical testing. Gastroenterology. 2017;153:439–447e2.
   PubMed Web of Science ®Google Scholar
• Digby J, Fraser CG, Carey FA, et al. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited. J Med Screen. 2016;23:130–134.
   PubMed Web of Science ®Google Scholar